Non-inflammatory Degenerative Joint Disease
0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Zimmer BiometFL - Jacksonville
3 programsA Clinical Investigation of the M2a- 38™ Hip SystemN/A1 trial
A Clinical Investigation of the M2a- Taper™ Hip SystemN/A1 trial
BC Study of G7 Cup and Compatible Femoral StemsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Zimmer BiometBC Study of G7 Cup and Compatible Femoral Stems
StrykerStryker Triathlon Primary Total Knee System
Zimmer BiometA Clinical Investigation of the M2a- 38™ Hip System
Zimmer BiometA Clinical Investigation of the M2a- Taper™ Hip System
Clinical Trials (4)
Total enrollment: 481 patients across 4 trials
BC Study of G7 Cup and Compatible Femoral Stems
Start: Nov 2015Est. completion: Dec 2030230 patients
N/AActive Not Recruiting
A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot
Start: Aug 2015Est. completion: Mar 201918 patients
N/ATerminated
A Clinical Investigation of the M2a- 38™ Hip System
Start: Jan 2002Est. completion: Dec 2008190 patients
N/ATerminated
A Clinical Investigation of the M2a- Taper™ Hip System
Start: Dec 2001Est. completion: Dec 200843 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.